Almirall has completed the decentralised European regulatory procedure for efinaconazole, a triazole antifungal substance ...

BARCELONA, Spain--(BUSINESS WIRE)--Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology, today announced its participation in the 33rd Congress of the European ...

Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology announced today the successful ...

Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United ...

Spanish dermatology specialist Almirall (BME: ALM) has announced the successful completion of the decentralized regulatory procedure in Europe for efinaconazole. The triazole antifungal compound is ...

Westminster Christian School senior Julia Almirall loves music. She plays violin, viola and piano. She also writes music and wants to continue taking music in college. “I want to do music production ...

With the addition of this treatment, Almirall enhances its European medical dermatology portfolio and reaffirms its commitment to people living with skin infections and dermatologists by providing ...

Almirall has completed the decentralised European regulatory procedure for efinaconazole, a triazole antifungal substance with the trade name Jublia, to treat onychomycosis. This is a significant ...

New clinical data on Almirall’s biologics portfolio demonstrates further opportunities to positively impact patients and the medical community New data to be presented on tildrakizumab for the ...

Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology announced today the successful completion of the decentralized regulatory procedure in Europe for ...